Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Lybe Scientific AS
AS
Active
Org 926682520
Laboratoriesenteret Erling Skjalgssons Gate 1, 7030
Trondheim
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2021 · 5 years old
5 employees
Monitor
Share
Norway
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Lybe Scientific AS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
TS
Tonje Strømmen Steigedal
Chief Executive Officer
Chief Executive Officer
2021
Board of directors
Non-executive oversight
Name
Role
Member since
Current (3)
MW
Mårten Wigstøl
Chairman
Chairman
2021
GØ
Gisle Østereng
Board of Directors
Board of Directors
2023
SB
Sulalit Bandyopadhyay
Board of Directors
Board of Directors
2021
Former (2)
MB
Magnar Bjørås
Board of Directors
Board of Directors
2021 – 2023
EA
Eivind Andersen
Board of Directors
Board of Directors
2021 – 2023
Shareholders
As of last annual report
Lybe Scientific As — 15.95%
Startuplab Founders Fund Iv As — 12.95%
Alacris As — 9.16%
Magnar Bjørås — 7.8%
Ntnu Technology Transfer As — 7.4%
Ystvika Holding As — 6.9%
Iso Invest As — 6.5%
Grotmol Solutions As — 4.75%
Tidligfasefondet As — 4.75%
Barracuda Invest As — 4.2%
Andvari Investment Research As — 3.56%
Sten Even Erlandsen — 3.53%
Gnist Capital As — 3.45%
Per Arne Aas — 3.25%
Vegar Ottesen — 1.95%
Lars Hagen — 1.95%
Anuvansh Sharma — 1.95%
100%
Shareholder
Type
Ownership
Votes
Since
Lybe Scientific As
Company
15.95%
15.95%
2025
Startuplab Founders Fund Iv As
Company
12.95%
12.95%
2025
Alacris As
Company
9.16%
9.16%
2025
Magnar Bjørås
Individual
7.8%
7.8%
2025
Ntnu Technology Transfer As
Company
7.4%
7.4%
2025
Ystvika Holding As
Company
6.9%
6.9%
2025
Iso Invest As
Company
6.5%
6.5%
2025
Grotmol Solutions As
Company
4.75%
4.75%
2025
Tidligfasefondet As
Company
4.75%
4.75%
2025
Barracuda Invest As
Company
4.2%
4.2%
2025
Andvari Investment Research As
Company
3.56%
3.56%
2025
Sten Even Erlandsen
Individual
3.53%
3.53%
2025
Gnist Capital As
Company
3.45%
3.45%
2025
Per Arne Aas
Individual
3.25%
3.25%
2025
Vegar Ottesen
Individual
1.95%
1.95%
2025
Lars Hagen
Individual
1.95%
1.95%
2025
Anuvansh Sharma
Individual
1.95%
1.95%
2025
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Lybe Scientific AS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network